Principal Investigator
Eugene Schiff
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230093
Clinical Trial Summary
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of
Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in
Subjects with Chronic Hepatitis B Virus Infection
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Hepatitis B
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu